82.08
price up icon1.99%   1.60
after-market Dopo l'orario di chiusura: 79.50 -2.58 -3.14%
loading
Precedente Chiudi:
$80.48
Aprire:
$80.14
Volume 24 ore:
326.74K
Relative Volume:
0.63
Capitalizzazione di mercato:
$5.45B
Reddito:
-
Utile/perdita netta:
$-224.29M
Rapporto P/E:
-21.05
EPS:
-3.9
Flusso di cassa netto:
$-185.06M
1 W Prestazione:
-4.21%
1M Prestazione:
+6.76%
6M Prestazione:
-0.18%
1 anno Prestazione:
+2.22%
Intervallo 1D:
Value
$80.14
$82.54
Intervallo di 1 settimana:
Value
$80.14
$86.49
Portata 52W:
Value
$55.53
$113.51

Nuvalent Inc Stock (NUVL) Company Profile

Name
Nome
Nuvalent Inc
Name
Telefono
508-446-2272
Name
Indirizzo
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
Name
Dipendente
162
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
NUVL's Discussions on Twitter

Confronta NUVL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NUVL
Nuvalent Inc
82.08 5.78B 0 -224.29M -185.06M -3.90
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Nuvalent Inc Stock (NUVL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-14 Aggiornamento UBS Neutral → Buy
2024-12-30 Iniziato H.C. Wainwright Buy
2024-10-24 Iniziato UBS Neutral
2024-08-29 Iniziato Barclays Overweight
2024-04-17 Iniziato Jefferies Buy
2024-04-01 Aggiornamento Leerink Partners Market Perform → Outperform
2024-02-28 Ripresa Guggenheim Buy
2024-02-23 Iniziato Robert W. Baird Outperform
2023-09-27 Iniziato Stifel Buy
2023-08-08 Iniziato SVB Securities Market Perform
2023-07-24 Iniziato Guggenheim Buy
2023-01-18 Iniziato Wedbush Outperform
2022-06-24 Iniziato BMO Capital Markets Outperform
Mostra tutto

Nuvalent Inc Borsa (NUVL) Ultime notizie

pulisher
Jul 24, 2025

What institutions are buying Nuvalent Inc. stock nowSky-high return potential - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Is Nuvalent Inc. a good long term investmentPowerful profit generation - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 23, 2025

Nuvalent Inc. Stock Analysis and ForecastHigh-yield capital appreciation - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Nuvalent Inc. stock priceConsistent triple returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Nuvalent Inc. stockExplosive earnings growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 21, 2025

Nuvalent Initiates Phase 3 ALKAZAR Trial of Neladalkib in NSCLC - Pharmacy Times

Jul 21, 2025
pulisher
Jul 21, 2025

Nuvalent begins Phase 3 trial of neladalkib in ALK-positive lung cancer - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

Nuvalent Initiates Phase 3 ALKAZAR Clinical Trial - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

Nuvalent doses first patient in phase 3 lung cancer drug trial - Investing.com Nigeria

Jul 21, 2025
pulisher
Jul 21, 2025

Nuvalent announces initiation of Alkazar phase 3 randomized - MarketScreener

Jul 21, 2025
pulisher
Jul 21, 2025

Nuvalent Announces Initiation of ALKAZAR Phase 3 Randomized, Controlled Trial Evaluating Neladalkib for Patients with TKI-naïve ALK-positive NSCLC - PR Newswire

Jul 21, 2025
pulisher
Jul 18, 2025

How high can Nuvalent Inc. stock price go in 2025Profitable Yet Secure Picks - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

Nuvalent(NUVL) Shares Soar 3.01% on Positive Clinical Data - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Stock Position Decreased by Teacher Retirement System of Texas - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

Why Nuvalent Inc. stock attracts strong analyst attentionDaily Trade Opportunity - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Nuvalent Inc. stock performs during market volatilityFree Capital Allocation Plans - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Nuvalent Inc. stock price move sharplyFree Access to Stock Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Recent Analysts’ Ratings Updates for Nuvalent (NUVL) - Defense World

Jul 15, 2025
pulisher
Jul 14, 2025

Insider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Insider Sells $439,890.00 in Stock - Defense World

Jul 14, 2025
pulisher
Jul 11, 2025

Nuvalent's Insider Sales and Clinical Milestones: A Balancing Act for Investors - AInvest

Jul 11, 2025
pulisher
Jul 09, 2025

Nuvalent(NUVL) Shares Soar 3.47% on Positive Lung Cancer Data - AInvest

Jul 09, 2025
pulisher
Jul 07, 2025

Nuvalent Announces Positive Pivotal Data for Zidesamtinib in Lung Cancer - MSN

Jul 07, 2025
pulisher
Jul 07, 2025

Nuvalent’s SWOT analysis: biotech stock’s pivotal year ahead By Investing.com - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 07, 2025

Nuvalent’s SWOT analysis: biotech stock’s pivotal year ahead - Investing.com

Jul 07, 2025

Nuvalent Inc Azioni (NUVL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):